Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021

Loading...
Loading...

Upgrades

For GoodRx Holdings Inc GDRX, Barclays upgraded the previous rating of Equal-Weight to Overweight. For the second quarter, GoodRx Holdings had an EPS of $0.08, compared to year-ago quarter EPS of $0.07. The current stock performance of GoodRx Holdings shows a 52-week-high of $64.22 and a 52-week-low of $26.66. Moreover, at the end of the last trading period, the closing price was at $36.78.

According to Cowen & Co., the prior rating for Textron Inc TXT was changed from Market Perform to Outperform. In the second quarter, Textron showed an EPS of $0.81, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $74.80 and a 52-week-low of $31.82. Textron closed at $71.94 at the end of the last trading period.

For Alliance Data Systems Corp ADS, B of A Securities upgraded the previous rating of Neutral to Buy. In the second quarter, Alliance Data Systems showed an EPS of $5.99, compared to $1.86 from the year-ago quarter. The stock has a 52-week-high of $128.16 and a 52-week-low of $39.77. At the end of the last trading period, Alliance Data Systems closed at $94.63.

BTIG upgraded the previous rating for Tyler Technologies Inc TYL from Neutral to Buy. In the second quarter, Tyler Technologies showed an EPS of $1.83, compared to $1.38 from the year-ago quarter. The current stock performance of Tyler Technologies shows a 52-week-high of $498.98 and a 52-week-low of $319.58. Moreover, at the end of the last trading period, the closing price was at $477.28.

Canaccord Genuity upgraded the previous rating for Digital Turbine Inc APPS from Hold to Buy. Digital Turbine earned $0.34 in the first quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Digital Turbine shows a 52-week-high of $102.56 and a 52-week-low of $20.60. Moreover, at the end of the last trading period, the closing price was at $51.24.

Raymond James upgraded the previous rating for BancorpSouth Bank BXS from Outperform to Strong Buy. In the second quarter, BancorpSouth Bank showed an EPS of $0.69, compared to $0.57 from the year-ago quarter. The current stock performance of BancorpSouth Bank shows a 52-week-high of $35.59 and a 52-week-low of $18.11. Moreover, at the end of the last trading period, the closing price was at $28.63.

According to Raymond James, the prior rating for Cadence Bancorp CADE was changed from Outperform to Strong Buy. In the second quarter, Cadence Bancorp showed an EPS of $0.84, compared to $0.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.88 and a 52-week-low of $7.73. Cadence Bancorp closed at $21.02 at the end of the last trading period.

Jefferies upgraded the previous rating for Funko Inc FNKO from Hold to Buy. For the second quarter, Funko had an EPS of $0.40, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $27.20 and a 52-week-low of $5.34. Funko closed at $18.65 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

Cowen & Co. downgraded the previous rating for DSP Group Inc DSPG from Outperform to Market Perform. DSP Group earned $0.12 in the second quarter, compared to $0.06 in the year-ago quarter. The current stock performance of DSP Group shows a 52-week-high of $22.00 and a 52-week-low of $12.42. Moreover, at the end of the last trading period, the closing price was at $21.99.

Needham downgraded the previous rating for DSP Group Inc DSPG from Buy to Hold. For the second quarter, DSP Group had an EPS of $0.12, compared to year-ago quarter EPS of $0.06. The current stock performance of DSP Group shows a 52-week-high of $22.00 and a 52-week-low of $12.42. Moreover, at the end of the last trading period, the closing price was at $21.99.

For Zymergen Inc ZY, UBS downgraded the previous rating of Buy to Neutral. Interestingly, in the second quarter, Zymergen's EPS was $1.30. The current stock performance of Zymergen shows a 52-week-high of $52.00 and a 52-week-low of $7.85. Moreover, at the end of the last trading period, the closing price was at $13.00.

See all analyst ratings downgrades.

Initiations

Citigroup initiated coverage on Occidental Petroleum Corp OXY with a Buy rating. The price target for Occidental Petroleum is set to $35.00. For the second quarter, Occidental Petroleum had an EPS of $0.32, compared to year-ago quarter EPS of $1.76. The stock has a 52-week-high of $33.50 and a 52-week-low of $8.52. At the end of the last trading period, Occidental Petroleum closed at $25.25.

For CA Healthcare Acquisition Corp CAHC, Ladenburg Thalmann initiated coverage, by setting the current rating at Buy. The current stock performance of CA Healthcare Acquisition shows a 52-week-high of $10.32 and a 52-week-low of $9.55. Moreover, at the end of the last trading period, the closing price was at $9.92.

Maxim Group initiated coverage on Palisade Bio Inc PALI with a Buy rating. The price target for Palisade Bio is set to $7.00. For the second quarter, Palisade Bio had an EPS of $0.75, compared to year-ago quarter EPS of $0.67. The current stock performance of Palisade Bio shows a 52-week-high of $10.91 and a 52-week-low of $2.34. Moreover, at the end of the last trading period, the closing price was at $2.73.

With a Buy rating, B. Riley Securities initiated coverage on Exela Technologies Inc XELA. The price target seems to have been set at $4.00 for Exela Technologies. In the second quarter, Exela Technologies showed an EPS of $0.33, compared to $0.34 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.82 and a 52-week-low of $0.33. Exela Technologies closed at $2.30 at the end of the last trading period.

Seaport Global initiated coverage on Berkshire Hills Bancorp Inc BHLB with a Buy rating. The price target for Berkshire Hills Bancorp is set to $30.00. In the second quarter, Berkshire Hills Bancorp showed an EPS of $0.44, compared to $0.13 from the year-ago quarter. The current stock performance of Berkshire Hills Bancorp shows a 52-week-high of $28.97 and a 52-week-low of $8.55. Moreover, at the end of the last trading period, the closing price was at $24.91.

Loading...
Loading...

Macquarie initiated coverage on PubMatic Inc PUBM with an Outperform rating. The price target for PubMatic is set to $37.00. In the second quarter, PubMatic earned $0.18. The stock has a 52-week-high of $76.96 and a 52-week-low of $22.42. At the end of the last trading period, PubMatic closed at $27.47.

With an Outperform rating, Macquarie initiated coverage on Magnite Inc MGNI. The price target seems to have been set at $39.00 for Magnite. For the second quarter, Magnite had an EPS of $0.11, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $64.39 and a 52-week-low of $5.57. At the end of the last trading period, Magnite closed at $28.41.

Macquarie initiated coverage on ironSource Ltd IS with a Neutral rating. The price target for ironSource is set to $11.00. ironSource earned $0.01 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.25 and a 52-week-low of $7.80. ironSource closed at $9.78 at the end of the last trading period.

Macquarie initiated coverage on AppLovin Corp APP with an Outperform rating. The price target for AppLovin is set to $90.00. In the second quarter, AppLovin showed an EPS of $0.04, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $90.03 and a 52-week-low of $49.41. At the end of the last trading period, AppLovin closed at $73.30.

With an Overweight rating, Cantor Fitzgerald initiated coverage on Redhill Biopharma Ltd RDHL. The price target seems to have been set at $22.00 for Redhill Biopharma. In the second quarter, Redhill Biopharma showed an EPS of $0.06, compared to $0.04 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.52 and a 52-week-low of $5.90. Redhill Biopharma closed at $8.59 at the end of the last trading period.

With a Buy rating, Jefferies initiated coverage on Virgin Galactic Holdings Inc SPCE. The price target seems to have been set at $33.00 for Virgin Galactic Hldgs. Virgin Galactic Hldgs earned $0.39 in the second quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $62.80 and a 52-week-low of $14.27. At the end of the last trading period, Virgin Galactic Hldgs closed at $24.88.

For First Financial Bankshares Inc FFIN, Janney Montgomery Scott initiated coverage, by setting the current rating at Neutral. For the second quarter, First Finl Bankshares had an EPS of $0.39, compared to year-ago quarter EPS of $0.38. The stock has a 52-week-high of $52.49 and a 52-week-low of $26.71. At the end of the last trading period, First Finl Bankshares closed at $47.53.

With a Neutral rating, Macquarie initiated coverage on Digital Turbine Inc APPS. The price target seems to have been set at $60.00 for Digital Turbine. In the first quarter, Digital Turbine showed an EPS of $0.34, compared to $0.13 from the year-ago quarter. The current stock performance of Digital Turbine shows a 52-week-high of $102.56 and a 52-week-low of $20.60. Moreover, at the end of the last trading period, the closing price was at $51.24.

Raymond James initiated coverage on Wheels Up Experience Inc UP with an Outperform rating. The price target for Wheels Up Experience is set to $10.00. Interestingly, in the second quarter, Wheels Up Experience's EPS was $0.12. At the moment, the stock has a 52-week-high of $15.00 and a 52-week-low of $6.65. Wheels Up Experience closed at $6.80 at the end of the last trading period.

Morgan Stanley initiated coverage on Adagio Therapeutics Inc ADGI with a Equal-Weight rating. The price target for Adagio Therapeutics is set to $33.00. The current stock performance of Adagio Therapeutics shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $32.34.

With a Buy rating, Jefferies initiated coverage on Adagio Therapeutics Inc ADGI. The price target seems to have been set at $60.00 for Adagio Therapeutics. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Adagio Therapeutics closed at $32.34.

With a Buy rating, Stifel initiated coverage on Adagio Therapeutics Inc ADGI. The price target seems to have been set at $57.00 for Adagio Therapeutics. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Adagio Therapeutics closed at $32.34.

Guggenheim initiated coverage on Adagio Therapeutics Inc ADGI with a Buy rating. The price target for Adagio Therapeutics is set to $40.00. The current stock performance of Adagio Therapeutics shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $32.34.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...